TWI340021B - Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof - Google Patents

Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof

Info

Publication number
TWI340021B
TWI340021B TW099109795A TW99109795A TWI340021B TW I340021 B TWI340021 B TW I340021B TW 099109795 A TW099109795 A TW 099109795A TW 99109795 A TW99109795 A TW 99109795A TW I340021 B TWI340021 B TW I340021B
Authority
TW
Taiwan
Prior art keywords
complication
diabetes
syndrome
improving
composition
Prior art date
Application number
TW099109795A
Other languages
Chinese (zh)
Other versions
TW201132286A (en
Inventor
Ying Chen Leu
Feng Ching Hsieh
Original Assignee
Genmont Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmont Biotech Inc filed Critical Genmont Biotech Inc
Priority to TW099109795A priority Critical patent/TWI340021B/en
Application granted granted Critical
Publication of TWI340021B publication Critical patent/TWI340021B/en
Publication of TW201132286A publication Critical patent/TW201132286A/en

Links

TW099109795A 2010-03-31 2010-03-31 Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof TWI340021B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW099109795A TWI340021B (en) 2010-03-31 2010-03-31 Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW099109795A TWI340021B (en) 2010-03-31 2010-03-31 Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof

Publications (2)

Publication Number Publication Date
TWI340021B true TWI340021B (en) 2011-04-11
TW201132286A TW201132286A (en) 2011-10-01

Family

ID=46750704

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099109795A TWI340021B (en) 2010-03-31 2010-03-31 Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof

Country Status (1)

Country Link
TW (1) TWI340021B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI505832B (en) * 2014-02-21 2015-11-01 Genmont Biotech Inc Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases
TWI627959B (en) * 2014-10-02 2018-07-01 景岳生物科技股份有限公司 Use of lactobacillus reuteri gmnl-263 for manufacturing composition for increasing expression of ldl-r and cyp7a1 in liver in high-fat diet individual
CN109983115A (en) * 2016-12-20 2019-07-05 深圳华大生命科学研究院 A kind of Lactobacillus gasseri and its cultural method and application
TWI709374B (en) * 2019-06-14 2020-11-11 豐華生物科技股份有限公司 Use of food composition and pharmaceutical composition with strains of lactic acid bacteria for modulating blood glucose

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568441B (en) * 2014-01-10 2017-02-01 景岳生物科技股份有限公司 A lactobacillus reuteri gmnl-263 composition for controlling body weight and its use thereof
TWI587865B (en) * 2014-03-07 2017-06-21 景岳生物科技股份有限公司 Composition and use of lactobacillus reuteri gmnl-89 in treating type 2 diabetes
TWI667344B (en) * 2018-04-20 2019-08-01 景岳生物科技股份有限公司 Lactobacillus reuteri strain GMNL-263 and composition thereof capable of improving hypertension

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI505832B (en) * 2014-02-21 2015-11-01 Genmont Biotech Inc Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases
US9980990B2 (en) 2014-02-21 2018-05-29 Genmont Biotech Incorporation Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases
US10646522B2 (en) 2014-02-21 2020-05-12 Genmont Biotech Incorporation Lactobacillus strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases
TWI627959B (en) * 2014-10-02 2018-07-01 景岳生物科技股份有限公司 Use of lactobacillus reuteri gmnl-263 for manufacturing composition for increasing expression of ldl-r and cyp7a1 in liver in high-fat diet individual
CN109983115A (en) * 2016-12-20 2019-07-05 深圳华大生命科学研究院 A kind of Lactobacillus gasseri and its cultural method and application
TWI709374B (en) * 2019-06-14 2020-11-11 豐華生物科技股份有限公司 Use of food composition and pharmaceutical composition with strains of lactic acid bacteria for modulating blood glucose

Also Published As

Publication number Publication date
TW201132286A (en) 2011-10-01

Similar Documents

Publication Publication Date Title
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
PL2431442T3 (en) Composition of 1,3,3,3-tetrafluoropropene
EP2588448A4 (en) Composition for light-emitting particle-polymer composite, light-emitting particle-polymer composite, and device including the light-emitting particle-polymer composite
EP2548948A4 (en) Novel lactobacillus classified as lactobacillus plantarum, and use thereof
PL3202870T3 (en) Use of a 2,3,3,3-tetrafluoropropene composition
IL226383B (en) Anti-ccl20 antibodies, compositions comprising the same and uses thereof
GB0902052D0 (en) Polymers,composition and use
IL215684B (en) Trehalulose-containing composition, its preparation and use
TWI340021B (en) Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof
SG11201400480SA (en) Polymer and composition including same, and adhesive composition
HK1182934A1 (en) Anti-fatigue composition, formulation and use thereof
EP2612887A4 (en) Polysiloxane composition, and cured product thereof
EP2600761A4 (en) Biosensor membrane composition, biosensor, and methods for making same
IL259652B (en) A bacterial strain, a composition comprising thereof and its uses
EP2550954A4 (en) Vaseline-like composition, and cosmetic preparation
IL223405B (en) Phosphaplatins, compositions comprising the same and uses thereof
EP2639265A4 (en) Chloroprene rubber composition, and vulcanizates and moldings thereof
EP2582851B8 (en) New strain of lactobacillus plantarum s, the use of the strain of lactobacillus plantarum s and the preparation for roughages ensiling
ZA201304439B (en) Anti-regurgitation and/or anti-gastro-oesophageal reflux composition,preparation and uses
AP2012006139A0 (en) Composition comprising strains of lactobacillus fermentum.
PL2407147T3 (en) Composition with bio-regenerative, restorative and eutrophying activity
IL215980A (en) Intermediate of ertapenem, composition comprising the same and preparation methods thereof
PL2539396T3 (en) Composite composition, method for the production thereof, moulded part and use
IL225440A (en) Cyclohexane derivatives, compositions comprising the same and uses thereof
EP2623593A4 (en) Novel aminotransferase and gene encoding same, and use of the aminotransferase and the gene